TAG:

genetic sequencing

Veritas Genetics to Close Its Testing Operations in U.S.

MAYBE CHARGING CONSUMERS THE LOW PRICE of $599 for a whole human genome sequence is not a winning financial strategy. That’s one possible reason why closely-watched Veritas Genetics of Cambridge, Mass., will stop operations in the United States. It was in July that Veritas annou…

Read More



Opko Pays $1.47 Billion to Buy Bio-Reference Lab

CEO SUMMARY: It’s a case of the little fish gobbling the big fish, as Opko Health – with revenue of $91 million – will be acquiring Bio-Reference Laboratories, with revenue of $832 million. But the more interesting aspect of the story is that the CEO of Opko Health is a physi…

Read More



Frederick Sanger Dies at Age 95, Hailed as Father of Genomics

EVERY DAY, ACROSS THE GLOBE, labs perform testing using Sanger sequencing and other fundamental techniques of proteomics and genomics pioneered and developed by Frederick Sanger, who died last month at the age of 95. Sanger is considered one of the giants in biochemistry. He was one of only three pe…

Read More



September 30, 2013 “Intelligence: Late Breaking Lab News”

Even as the cost of genetic sequencing falls, the number of gene profiles in data repositories increases. This month, a research project in Boston, Massachusetts, that includes Dana-Farber Cancer Institute, Brigham and Women’s Hospital, and Boston Children…

Read More



June 25, 2012 “Intelligence: Late Breaking Lab News”

Earlier this month, the clinical laboratory at Ohio State University Wexner Medical Center (OSUWMC) was sent a letter by federal CLIA (Clinical Laboratory Improvement Act) officials declaring that the laboratory was in violation of proficiency testing (PT) regulation…

Read More



June 4, 2012 “Intelligence: Late Breaking Lab News”

It’s a milestone on the path to personalized medicine and an example of how integrated health informatics will give clinicians real-time access to unlimited amounts of medical data. The 1000 Genomes Project announced in recent months that “the world’s largest set of data on hum…

Read More



Roche Offers $5.7 Billion To Acquire Illumina Inc.

CEO SUMMARY: Once again, Roche is hunting for gene sequencing and gene analysis technology that can support its goal of being a world leader in gene-based therapeutics and clinical lab testing that utilizes gene tests and molecular diagnostics. Last week, Roche launched a hostile stock te…

Read More



Genetic Testing Genie Is Now Out of the Bottle

CEO SUMMARY: There’s been an uneasy standoff between companies that want to sell genetic tests directly to consumers over the Internet and both state and federal regulators. But now it appears that the FDA is ready to take off the gloves and assert greater control over genetic …

Read More



Luminex and PerkinElmer Ink Licensing Agreement

CEO SUMMARY: PerkinElmer’s interest in the multiplex capabilities of Luminex’s xMap technology led to this new licensing agreement. PerkinElmer’s instrument systems played a major role in accelerating the work of the Human Genome Project. Now, besides bioresearch applications, Perki…

Read More



How Much Laboratory Business Intelligence Have You Missed?

Lab leaders rely on THE DARK REPORT for actionable intelligence on important developments in the business of laboratory testing. Maximize the money you make-and the money you keep! Best of all, it is released every three weeks!

Sign up for TDR Insider

Join the Dark Intelligence Group FREE and get TDR Insider FREE!
Never miss a single update on the issues that matter to you and your business.